Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cellular & Molecular Immunology|May 20, 2020
MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cellsXiaoguang Wang, Brittany C Waschke, Rachel A Woolaver, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
PRDX6 Modulates Immune Checkpoint Inhibitor Response by Antagonizing Ferroptosis Induced By HDAC InhibitorsZeyu Liu, Jessy John, Nickolas Johnson, et al.
Cancer Immunology Research|June 26, 2019
Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell LymphomasXiaoguang Wang, Brittany C Waschke, Rachel A Woolaver, et al.
Frontiers in Immunology|April 13, 2023
Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-respondersJessy John, Samantha M Y Chen, Rachel A Woolaver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and AnergyZhangguo Chen, Alexandra Krinsky, Rachel A Woolaver, et al.
The Journal of Experimental Medicine|February 10, 2010
Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4Cristian Boboila, Catherine Yan, Duane R Wesemann, et al.
International Journal of Molecular Sciences|November 27, 2024
Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening ApproachMohamed Y Zaky, Jessy John, Monika Vashisht, et al.
Frontiers in Immunology|July 26, 2024
Differential tumor immune microenvironment coupled with tumor progression or tumor eradication in HPV-antigen expressing squamous cell carcinoma (SCC) modelsArpitha H Shivarudrappa, Jessy John, Monika Vashisht, et al.
Elife|June 26, 2024
FAK loss reduces BRAFV600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formationChenxi Gao, Huaibin Ge, Shih-Fan Kuan, et al.
Journal of Hematology & Oncology|January 8, 2016
Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneityZhangguo Chen, Mihret T Elos, Sawanee S Viboolsittiseri, et al.
Pageof 6